Trial intelligence / Profile preview

Phase III trial of freeze-dried human diploid cell rabies vaccine using different post-exposure immunization schedules

CTR20211392Phase 3Completed

Sponsor
Liaoning Chengda Biotechnology Co., Ltd.
Start
Jun 2021
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of rabies virus inactivated antigen, B in rabies, sponsored by Liaoning Chengda Biotechnology Co., Ltd.. Started Jun 2021; status: completed.

02

Drugs

rabies virus inactivated antigen, B
03

Conditions

rabies

Beyond the preview

Go deeper on CTR20211392.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20211392.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call